« Previous
Next »
Titles
- Understanding coverage considerations for COVID-19 vaccines and treatments2
- COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 20221
- Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry1
- Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary1
- Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update1
- Variation in use of anti-SARS-CoV-2 monoclonal antibody therapies by social vulnerability and urbanicity1